Resources

Novel Coronavirus (COVID-19) Tracking Report—Wave 3

Wave 4 of this Tracking Report is now available here!

With the recent outbreak of the novel coronavirus (COVID-19) and cases identified in the US, InCrowd wanted to understand and track treating physicians’ perceptions on the spread of the virus, preparedness, physician concerns, patient concerns, and numbers of inflicted patients.

Methodology:

  • Method: 10-minute MicroSurvey via InCrowd
  • Crowds: US Primary Care Physicians (PCPs), Pediatricians (PEDs), and Emergency Medicine or Critical Care Physicians (EMCCs)
  • Sample Size: n=263
  • Wave 1 Fielding Period: Jan. 31-Feb. 4, 2020
  • Wave 2 Fielding Period: Feb. 26-27, 2020
  • Wave 3 Fielding Period: Mar. 19-20, 2020

Screening Criteria:
Physicians have or are currently treating 20 or more patients with flu like symptoms

Please fill out the form below to access this content

Name(Required)
This field is for validation purposes and should be left unchanged.

Related Resources

Instant Insights – Weight Loss Drugs

Instant Insights – Weight Loss Drugs

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...

read more
Post-ASCO Excitement Report

Post-ASCO Excitement Report

Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...

read more
2023 Q1 – NSCLC Essentials Readout

2023 Q1 – NSCLC Essentials Readout

Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...

read more